Psychedelics get a hearing at FDA
The Trump administration has signaled it's behind the psychedelic renaissance, but there are still big questions about how these drugs will be administered once they are approved by the FDA.
We haven't written up this one. NPR Health has the full story — the link below goes straight to it.